GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Multicell Technologies MCET · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Multicell Technologies — daily MCET Delayed
Market value
$3,726
Last close × shares
Volume
350k
Shares, 9 Nov 2026

About Multicell Technologies

Its shares trade under the ticker MCET. It has been listed since 16 June 1994. In the fiscal year to 30 November 2014, it reported revenue of $49,300 and a net loss of $380,100. At that date it held total assets of $126,200 and shareholders' equity of −$144,300.

MultiCell Technologies, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Woonsocket, Rhode Island. The firm and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications. The firm's portfolio of lead drug candidates is in various stages of discovery optimization, and preclinical and clinical development, and includes MCT-125, MCT-465, MCT-475 and MCT-485. MCT-125 is a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue. MCT-465 is a preclinical synthetic double-stranded ribonucleic acid (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers. MCT-475 is a discovery-stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers. MCT-485 is a discovery-stage dsRNA therapeutic candidate for the treatment of certain cancers.

Figures and description from our data supplier, not checked against the company's own report.

More about Multicell Technologies →

Latest on Multicell Technologies

Our reporting

We have not reported on Multicell Technologies yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Multicell Technologies's ticker?

Multicell Technologies trades as MCET on its US listing, under ISIN US62544S2005.

What was Multicell Technologies's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.